Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

The BC Bud Corporation BCBCF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

The BC Bud Corporation (BCBCF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.04. It has a SharesGrow Score of 22/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $61,482, +13520.5%/yr average growth. Net income is $1M (loss), growing at -612.6%/yr. Net profit margin is -1990.9% (negative). Gross margin is 96.8% (+74.2 pp trend).

Balance sheet: total debt is $229,355 against $6,062 equity (Debt-to-Equity (D/E) ratio 37.83, leveraged). Current ratio is 0.96 (tight liquidity). Debt-to-assets is 36.3%. Total assets: $632,066.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

BCBCF SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BCBCF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
BCBCF: +13520.5%/yr revenue is, -612.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
~
MOAT Partial
50/100
BCBCF: Gross margin is 96.8% (+74.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BCBCF: Net profit margin is -1990.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.003-0.1166
Volume14K
Avg Volume (30D)19.56K
Market Cap$5.98M
Beta (1Y)1.98
Share Statistics
EPS (TTM)-0.03
Shares Outstanding$46.23M
IPO Date2022-04-29
CEOBrayden Robert Sutton
Financial Highlights & Ratios
Revenue (TTM)$61.48K
Gross Profit$59.5K
EBITDA$-1.2M
Net Income$-1.22M
Operating Income$-1.22M
Total Cash$4.2K
Total Debt$229.36K
Net Debt$225.15K
Total Assets$632.07K
Price / Earnings (P/E)-1.4
Price / Sales (P/S)97.27
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA05553A1075

Price Chart

Track all markets on TradingView
BCBCF
The BC Bud Corporation ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.12

People Also View

APNHF
APNHF
Aspen Pharmacare Holdings Limited
$8.69
+5.98%
 ATHJF
ATHJF
Antisense Therapeutics Limited
$0.01
-76.00%
 AVCNF
AVCNF
Avicanna Inc.
$0.11
-2.06%
 CRRTF
CRRTF
Crescita Therapeutics Inc.
$0.54
+0.00%
 ABTI
ABTI
Alterola Biotech, Inc.
$0.01
+0.00%
 ANTCF
ANTCF
Aion Therapeutic Inc.
$0.00
+0.00%
 ACNNF
ACNNF
AusCann Group Holdings Ltd
$0.00
-15.56%
 BINP
BINP
Bionoid Pharma Inc.
$0.03
0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message